Comerica Securities’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
Comerica Securities's RMD Position: Q1 2023 in Review
Comerica Securities sold out of ResMed (RMD) in Q1 2023, closing a stake of 679 shares — an estimated $141K sold.
Comerica Securities first reported a position in RMD in Q1 2019 and held it in 14 quarters. The position peaked at $608K in Q4 2020. 676 funds tracked by Wall St. Rank hold RMD as of Q1 2023.
- Comerica Securities reported no remaining ResMed position as of Q1 2023 after selling out during the quarter.
- Comerica Securities sold 679 ResMed shares in Q1 2023, an estimated $141K.
- Comerica Securities first reported a position in ResMed in Q1 2019 and held it in 14 quarters.
- Comerica Securities's ResMed position peaked at $608K in Q4 2020.
- 676 funds tracked by Wall St. Rank held ResMed as of Q1 2023.
Based on Comerica Securities's 13F filing for Q1 2023, filed 27 Apr 2023.